Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

553 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Decreased liver B vitamin-related enzymes as a metabolic hallmark of cancer cachexia.
Kojima Y, Mishiro-Sato E, Fujishita T, Satoh K, Kajino-Sakamoto R, Oze I, Nozawa K, Narita Y, Ogata T, Matsuo K, Muro K, Taketo MM, Soga T, Aoki M. Kojima Y, et al. Among authors: muro k. Nat Commun. 2023 Oct 6;14(1):6246. doi: 10.1038/s41467-023-41952-w. Nat Commun. 2023. PMID: 37803016 Free PMC article.
Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma.
Habu T, Kumanishi R, Ogata T, Fujisawa T, Mishima S, Kotani D, Kadowaki S, Nakamura M, Hojo H, Fujiwara H, Kumagai S, Koyama S, Fujita T, Kinoshita T, Nishikawa H, Yano T, Tajika M, Muro K, Mitsunaga S, Kojima T, Bando H. Habu T, et al. Among authors: muro k. Esophagus. 2023 Jul;20(3):533-540. doi: 10.1007/s10388-023-00987-0. Epub 2023 Feb 8. Esophagus. 2023. PMID: 36750480
Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study.
Iwasa S, Wang ZX, Muro K, Morita S, Park YS, Zhang D, Yamada Y, Sakamoto J, Kim TW. Iwasa S, et al. Among authors: muro k. Cancer Commun (Lond). 2023 Apr;43(4):519-522. doi: 10.1002/cac2.12406. Epub 2023 Jan 16. Cancer Commun (Lond). 2023. PMID: 36647206 Free PMC article. No abstract available.
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
Shitara K, Muro K, Watanabe J, Yamazaki K, Ohori H, Shiozawa M, Takashima A, Yokota M, Makiyama A, Akazawa N, Ojima H, Yuasa Y, Miwa K, Yasui H, Oki E, Sato T, Naitoh T, Komatsu Y, Kato T, Mori I, Yamanaka K, Hihara M, Soeda J, Misumi T, Yamamoto K, Yamashita R, Akagi K, Ochiai A, Uetake H, Tsuchihara K, Yoshino T. Shitara K, et al. Among authors: muro k. Nat Med. 2024 Mar;30(3):730-739. doi: 10.1038/s41591-023-02791-w. Epub 2024 Feb 12. Nat Med. 2024. PMID: 38347302 Free PMC article.
[Lower G. I./Colon and Rectum Cancer].
Muro K. Muro K. Gan To Kagaku Ryoho. 2023 Nov;50(11):1160-1161. Gan To Kagaku Ryoho. 2023. PMID: 38056866 Japanese. No abstract available.
Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry.
Suzuki S, Takahashi A, Ishikawa T, Akazawa K, Katai H, Isobe Y, Miyashiro I, Ono H, Tanabe S, Fukagawa T, Muro K, Nunobe S, Kadowaki S, Suzuki H, Irino T, Usune S, Miyata H, Kakeji Y; Registration Committee of the Japanese Gastric Cancer Association. Suzuki S, et al. Among authors: muro k. Gastric Cancer. 2021 May;24(3):545-566. doi: 10.1007/s10120-021-01178-5. Epub 2021 Apr 3. Gastric Cancer. 2021. PMID: 33811588
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.
Kato K, Kojima T, Hara H, Tsuji A, Yasui H, Muro K, Satoh T, Ogata T, Ishihara R, Goto M, Baba H, Nishina T, Han S, Iwakami K, Yatsuzuka N, Doi T. Kato K, et al. Among authors: muro k. Esophagus. 2024 Apr 12. doi: 10.1007/s10388-024-01053-z. Online ahead of print. Esophagus. 2024. PMID: 38607538
553 results